HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
February 5, 2021 by Brigid Hasson Uncategorized 0 comments
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding FDA’s recently published list of essential medicines, medical countermeasures (MCM), and their critical inputs. HSCA and our member companies are committed to ensuring continued patient access to critical medical products.
Click here to read the full comments.
HSCA Applauds House Judiciary Committee for Advancing the CREATES Act
April 30, 2019
Washington, DC (April 30, 2019) – Healthcare Supply Chain Association (HSCA)...
HSCA Applauds Senators Collins and Smith for Bipartisan Legislation to Prevent and Mitigate Drug Shortages
October 30, 2019
Washington, DC (October 30, 2019) – Healthcare Supply Chain Association (HSCA)...
Joint Letter of Support for the MEDS Act
November 5, 2019
Dear Senator Collins and Senator Smith, The undersigned organizations are...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
March 3, 2020
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...